176 related articles for article (PubMed ID: 8049463)
1. DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Pedersen L; Larsen JK; Christensen IJ; Lykkesfeldt A; Holck S; Schiødt T
Breast Cancer Res Treat; 1994; 29(3):297-306. PubMed ID: 8049463
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
Cook DL; Weaver DL
Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
4. Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.
Bergers E; van Diest PJ; Baak JP
J Clin Pathol; 1996 Nov; 49(11):931-7. PubMed ID: 8944615
[TBL] [Abstract][Full Text] [Related]
5. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
[TBL] [Abstract][Full Text] [Related]
6. Prognostic comparison of three classifications for medullary carcinomas of the breast.
Jensen ML; Kiaer H; Andersen J; Jensen V; Melsen F
Histopathology; 1997 Jun; 30(6):523-32. PubMed ID: 9205856
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
8. Effect of DNA ploidy classification on prognosis in breast cancer.
Joensuu H; Alanen K; Falkmer UG; Klemi P; Nordling S; Remvikos Y; Toikkanen S
Int J Cancer; 1992 Nov; 52(5):701-6. PubMed ID: 1428229
[TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
10. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.
Pedersen L; Holck S; Schiødt T; Zedeler K; Mouridsen HT
Breast Cancer Res Treat; 1989 Oct; 14(1):91-9. PubMed ID: 2605345
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
[TBL] [Abstract][Full Text] [Related]
14. [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].
Pinto AE; Pereira T; Silva GL; Ferreira MC; André S
Acta Med Port; 2012; 25(6):399-407. PubMed ID: 23534591
[TBL] [Abstract][Full Text] [Related]
15. Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction.
Collan Y; Klemi P; Kallioniemi OP; Joensuu H; Nordling S; Eskelinen M
Pathol Res Pract; 1992 Jun; 188(4-5):581-6. PubMed ID: 1409093
[TBL] [Abstract][Full Text] [Related]
16. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
17. Ploidy pattern and cell cycle in breast cancer as detected by image analysis and flow cytometry.
Luzi P; Bruni A; Mangiavacchi P; Cevenini G; Marini D; Tosi P
Cytometry; 1994 Jun; 18(2):79-87. PubMed ID: 7924702
[TBL] [Abstract][Full Text] [Related]
18. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
19. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy analyses in 218 consecutive Pakistani breast cancer patients: does it add anything?
Khan E; Mapara Z; Khan S; Arshad N; Siddiqui T; Pervez S
Pathol Oncol Res; 2001; 7(2):125-8. PubMed ID: 11458275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
